Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations

被引:0
|
作者
Kawasaki, T [1 ]
Tomita, Y [1 ]
Bilim, V [1 ]
Takeda, M [1 ]
Takahashi, K [1 ]
Kumanishi, T [1 ]
机构
[1] NIIGATA UNIV,BRAIN RES INST,DEPT MOL NEUROPATHOL,NIIGATA 951,JAPAN
关键词
D O I
10.1002/(SICI)1097-0215(19961115)68:4<501::AID-IJC16>3.0.CO;2-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The P53-inducible cyclin-dependent kinase inhibitor, p21/WAF1/CIP1 (P21), plays a pivotal role in the G(1) arrest or apoptosis of cells exposed to genotoxic stimuli. To determine whether p21 is a putative tumor-suppressor gene, p21 status was investigated in 4 human bladder-cancer cell lines of known p53 status. A p21-gene mutation, one base-pair insertion at codon 20 resulting in a chain-termination change at codon 35, was observed in one cell line, HT1376, suggesting structural or functional alteration of the p21 protein. When exposed to DNA-damaging agents, cisplatin or mitomycin C, apoptosis was induced in RT4 with the wild-type (wt) p53/wt p21, whereas T24 with the p53 non-sense mutation/wt p21 was resistant. Of the other 2 cell lines with the p53 mis-sense mutation, apoptosis was induced in SCaBER with the wt p21, but HT1376 with the p21 frame-shift mutation was fairly resistant. These findings suggest that not only p53 alteration, but also P21 alteration, is important to prevent apoptosis induced by DNA-damaging agents. When exposed to these agents, p53 and p21 expression was increased in RT4, and not induced in T24. p53 was not induced, but PZ I expression was increased in SCaBER, whereas p53 expression was increased but PZ I expression was absent in HT1376. Thus, p21 expression itself may have an important role in the induction of apoptosis by DNA-damaging agents. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:501 / 505
页数:5
相关论文
共 50 条
  • [21] Activation of p21(WAF1/Cip1) expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis
    Kobayashi, T
    Consoli, U
    Andreeff, M
    Shiku, H
    Deisseroth, AB
    Zhang, W
    ONCOGENE, 1995, 11 (11) : 2311 - 2316
  • [22] RB regulates transcription of the p21/WAF1/CIP1 gene
    Julien T Decesse
    Souhila Medjkane
    Michael B Datto
    Chantal E Crémisi
    Oncogene, 2001, 20 : 962 - 971
  • [23] Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer
    Tang, Kun
    Wang, Chenghe
    Chen, Zhong
    Xu, Hua
    Ye, Zhangqun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 4999 - 5007
  • [24] Gene therapy for head and neck cancer - Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21)
    Clayman, GL
    Liu, TJ
    Overholt, SM
    Mobley, SR
    Wang, M
    Janot, F
    Goepfert, H
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1996, 122 (05) : 489 - 493
  • [25] Abnormal p53 and p21(WAF1/CIP1) expression in Tamoxifen associated endometrial carcinomas
    Palazzo, J
    Ramondetta, L
    Dunton, C
    Kovatich, A
    LABORATORY INVESTIGATION, 1997, 76 (01) : 619 - 619
  • [26] p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells
    Gorospe, M
    Cirielli, C
    Wang, XT
    Seth, P
    Capogrossi, MC
    Holbrook, NJ
    ONCOGENE, 1997, 14 (08) : 929 - 935
  • [27] Expression of p21(CIP1/WAF1) in chondrocytes
    Stewart, MC
    Farnum, CE
    McLeod, JN
    CALCIFIED TISSUE INTERNATIONAL, 1997, 61 (03) : 199 - 204
  • [28] P53, THROUGH P21 (WAF1/CIP1), INDUCES CYCLIN D1 SYNTHESIS
    CHEN, XB
    BARGONETTI, J
    PRIVES, C
    CANCER RESEARCH, 1995, 55 (19) : 4257 - 4263
  • [29] P21 (Waf1/CIP1) in invasive transitional cell carcinoma
    Tomaszewski, JE
    McGarvey, TW
    Caron, R
    Montone, MT
    Malkowicz, SB
    LABORATORY INVESTIGATION, 1996, 74 (01) : 485 - 485
  • [30] RB regulates transcription of the p21/WAF1/CIP1 gene
    Decesse, JT
    Medjkane, S
    Datto, MB
    Crémisi, CE
    ONCOGENE, 2001, 20 (08) : 962 - 971